EpilepsyGTx raises $33 million Series A to develop gene therapy for epilepsy. The funding will advance their lead program EPY201 through Phase 1/2a trials.
Amount Raised
$33 Million
Round Type
Series A
LondonBiotechnologyHealth CareTherapeuticsInvestors
Description
EpilepsyGTx has raised $33 million in a Series A financing round to develop its lead program EPY201 for treating focal refractory epilepsy. The round included investments from XGEN Venture, the British Business Bank, and a global biopharmaceutical company. This funding will facilitate critical Phase 1/2a clinical trials to assess safety and efficacy. The company aims to provide transformative gene therapies to improve patients' lives.
Quick answer
EpilepsyGTx raised $33 Million in a Series A round, dated December 10, 2025. Investors: A Global Biopharmaceutical Company, British Business Bank and XGEN Venture. EpilepsyGTx is based in London, England, United Kingdom.
- How much did EpilepsyGTx raise?
- EpilepsyGTx raised $33 Million in a Series A round on December 10, 2025.
- Who invested in EpilepsyGTx?
- A Global Biopharmaceutical Company, British Business Bank and XGEN Venture are named as investors in this round.
- What does EpilepsyGTx do?
- EpilepsyGTx is a late preclinical-stage biotech developing cutting-edge gene therapies that will transform the management of focal refractory epilepsy (FRE).
- Where is EpilepsyGTx based and how big is it?
- EpilepsyGTx is based in London, England, United Kingdom. Fundz records about 2 employees.
- Who are the decision-makers at EpilepsyGTx?
- Fundz holds 2 contacts at EpilepsyGTx. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as EpilepsyGTx that raised within 45 days of this round, from Fundz verified event records.
- Corxel Pharmaceuticals raised $287M (Series D) on January 22, 2026.
- ImmunoMet Therapeutics raised $842K on January 21, 2026.
- Os Therapies raised $3.5M on January 14, 2026.
- Vivere Oncotherapies raised $10M (Funding Round) on January 13, 2026.
- Tessera Defense & Homeland Security Inc. raised $3.3M on January 13, 2026.
- Aurora Therapeutics raised $16M (Seed) on January 9, 2026.
Who to call at EpilepsyGTx, and when
A new round usually means EpilepsyGTx is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day EpilepsyGTx raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at EpilepsyGTx, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at EpilepsyGTx. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment EpilepsyGTx raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansEpilepsyGTx raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.